Global Hepatitis B Vaccines Business Research Report 2024: Market to Reach $3.9 Billion by 2030 from $2.9 Billion in 2023 with Combination Vaccines Accounting for $2.6 Billion [Yahoo! Fina...
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Dynavax Technologies Corporation (DVAX)
Last dynavax technologies corporation earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dynavax.com
Company Research
Source: Yahoo! Finance
Global Hepatitis B Vaccines Market to Reach $3.9 Billion by 2030 The global market for Hepatitis B Vaccines estimated at US$2.9 Billion in the year 2023, is projected to reach a revised size of US$3.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Combination Vaccines, one of the segments analyzed in the report, is expected to record 4.3% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Mono Vaccines segment is estimated at 3.1% CAGR for the next 8-year period. The U.S. Market is Estimated at $781.1 Million, While China is Forecast to Grow at 6.2% CAGR The Hepatitis B Vaccines market in the U.S. is estimated at US$781.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$832 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow
Show less
Read more
Impact Snapshot
Event Time:
DVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVAX alerts
High impacting Dynavax Technologies Corporation news events
Weekly update
A roundup of the hottest topics
DVAX
News
- TwoStep Therapeutics Launches with Funding to Advance Broadly Applicable Targeting Platform for Solid Tumors [Yahoo! Finance]Yahoo! Finance
- Dynavax to Present at Upcoming Investor ConferencesPR Newswire
- Dynavax Technologies Co. (NASDAQ: DVAX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Dynavax Technologies Co. (NASDAQ: DVAX) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- UPDATE 1-US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine [Yahoo! Finance]Yahoo! Finance
DVAX
Earnings
- 5/8/24 - Miss
DVAX
Analyst Actions
- 5/9/24 - HC Wainwright
DVAX
Sec Filings
- 6/3/24 - Form 4
- 5/28/24 - Form 4
- 5/28/24 - Form 4
- DVAX's page on the SEC website